Combination therapy with PM00 104 and another antitumor agent

Details for Australian Patent Application No. 2009246130 (hide)

Owner Pharma Mar, S.A.

Inventors Guillen Navarro, Maria Jose; Aviles Marin, Pablo Manuel; Lepage, Doreen

Agent Shelston IP

Pub. Number AU-A-2009246130

PCT Pub. Number WO2009/140675

Priority 61/053,726 16.05.08 US

Filing date 18 May 2009

Wipo publication date 19 November 2009

International Classifications

A61K 31/282 (2006.01)

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/436 (2006.01)

A61K 31/4745 (2006.01)

A61K 31/4995 (2006.01) - Pyrazines or piperazines forming part of bridged ring systems

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/704 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

9 December 2010 PCT application entered the National Phase

  PCT publication WO2009/140675 Priority application(s): WO2009/140675

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009246134-Genetic alterations on chromosomes 21q, 6q and 15q and methods of use thereof for the diagnosis and treatment of type 1 diabetes

2009246128-Thermal compress system and methods of using the same